Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Doherty

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
The Oncologist|July 3, 2021
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung CancerMichael C Tjong, Mark Doherty, Hendrick Tan, et al.
The Journal of Infectious Diseases|November 27, 2009
High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis diseaseAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Chest|December 31, 2009
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescentsCaroline J Gallant, Aurelie Cobat, Leah Simkin, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Future Oncology (London, England)|May 7, 2020
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)Mairéad Geraldine McNamara, Lipika Goyal, Mark Doherty, et al.
Journal of Thoracic Disease|March 13, 2023
Dyspnea in patients with stage IV non-small cell lung cancer: a population-based analysis of disease burden and patterns of careMichael Yan, Michael Tjong, Wing C Chan, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 24, 2024
A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, CanadaVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
The Oncologist|July 3, 2021
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung CancerMichael C Tjong, Mark Doherty, Hendrick Tan, et al.
The Journal of Infectious Diseases|November 27, 2009
High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis diseaseAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Chest|December 31, 2009
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescentsCaroline J Gallant, Aurelie Cobat, Leah Simkin, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Future Oncology (London, England)|May 7, 2020
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)Mairéad Geraldine McNamara, Lipika Goyal, Mark Doherty, et al.
Journal of Thoracic Disease|March 13, 2023
Dyspnea in patients with stage IV non-small cell lung cancer: a population-based analysis of disease burden and patterns of careMichael Yan, Michael Tjong, Wing C Chan, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 24, 2024
A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, CanadaVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Pageof 15